Getinge AB (publ) (BIT:1GETI)

Revenue Breakdown

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Revenue	18.68B	17.95B
Acute Care Therapies Revenue Growth	4.05%	8.58%
Life Science Revenue	4.50B	4.55B
Life Science Revenue Growth	-1.19%	5.25%
Surgical Workflows Revenue	11.80B	12.26B
Surgical Workflows Revenue Growth	-3.77%	11.70%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Americas Revenue	15.69B	15.52B
Americas Revenue Growth	1.10%	18.03%
APAC Revenue	6.94B	7.06B
APAC Revenue Growth	-1.67%	1.70%
EMEA Revenue	12.34B	12.18B
EMEA Revenue Growth	1.30%	3.77%

Revenue Breakdown 2

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Capital Goods Revenue	11.97B	12.42B
Capital Goods Revenue Growth	-3.65%	-0.43%
Product Sales Recurring Revenue	16.19B	15.59B
Product Sales Recurring Revenue Growth	3.83%	20.26%
Service Assignments Incl. Spare Parts Recurring Revenue	6.82B	6.75B
Service Assignments Incl. Spare Parts Recurring Revenue Growth	0.96%	5.62%
Total Recurring Revenue	23.00B	22.34B
Total Recurring Revenue Growth	2.97%	15.42%

Gross Profit

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Gross Profit	10.42B	9.62B
Acute Care Therapies Gross Profit Growth	8.37%	6.49%
Life Science Gross Profit	1.56B	1.70B
Life Science Gross Profit Growth	-8.25%	18.52%
Surgical Workflows Gross Profit	4.68B	4.84B
Surgical Workflows Gross Profit Growth	-3.37%	20.00%

EBIT

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Operating Profit	3.02B	2.07B
Acute Care Therapies Operating Profit Growth	46.29%	-35.77%
Life Science Operating Profit	470.00M	526.00M
Life Science Operating Profit Growth	-10.65%	33.16%
Surgical Workflows Operating Profit	773.00M	703.00M
Surgical Workflows Operating Profit Growth	9.96%	4.15%
Group Functions and Other Items Operating Profit	-474.00M	-440.00M

Adjusted EBITDA

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Adjusted EBITA	3.76B	3.55B
Acute Care Therapies Adjusted EBITA Growth	5.88%	14.02%
Life Science Revenue Adjusted EBITA	490.00M	608.00M
Life Science Revenue Adjusted EBITA Growth	-19.41%	41.39%
Surgical Workflows Adjusted EBITA	1.08B	1.09B
Surgical Workflows Adjusted EBITA Growth	-1.19%	51.18%
Group Functions and Other Items Adjusted EBITA	-450.00M	-383.00M

Key Performance Indicators

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies - Order Intake	18.22B	17.72B
Acute Care Therapies - Order Intake Growth	2.83%	8.21%
Life Science - Order Intake	4.25B	4.60B
Life Science - Order Intake Growth	-7.58%	10.92%
Surgical Workflows - Order Intake	11.55B	11.91B
Surgical Workflows - Order Intake Growth	-3.01%	14.86%
Total Order Intake	34.03B	34.23B
Total Order Intake Growth	-0.60%	10.80%
Order Intake - Organic Growth	3.50%	6.30%
Acute Care Therapies Net Sales - Organic Growth	7.00%	8.20%
Life Science Net Sales - Organic Growth	4.10%	-1.90%
Surgical Workflows Net Sales - Organic Growth	2.10%	2.60%
Total Net Sales - Organic Growth	4.90%	4.90%

Updated Dec 31, 2025. Data Source: Fiscal.ai.